Home Articles 2005 Page 2

2005

Random

Sales Rep Assessment: Shoot the Messenger, the Message, or Both?

Pharma Guy - November 1, 2005

Does the FDA Need to be Overhauled?

Pharma Guy - February 1, 2005

Is an FDA Drug Risk Advisory System Needed? Survey Results

Pharma Guy - June 1, 2005

The Evolving Impact of Anti-Spam Legislation on Online Marketers

Pharma Guy - September 1, 2005

Thought-Leader Management: A Challenge Met

Pharma Guy - May 1, 2005

Translate Industry Trends into the Optimal Promotional Strategy

Pharma Guy - July 1, 2005

Marketing’s Role in Limiting Physician Access and What to Do About...

Pharma Guy - March 1, 2005

Numbers, Math and Communicating Risk

Pharma Guy - February 1, 2005

Separation of Church and State

Pharma Guy - April 1, 2005

Give Docs What They Want

Pharma Guy - April 1, 2005

123...7 Page 2 of 7

EDITOR PICKS

Inside THCP2026: How Pharma Is Rethinking Transparency, HCP Engagement and Compliance

August 14, 2026

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

TrumpRx pharma marketing concept showing prescription drug discovery, pricing, pharmacy access, and the federal government’s role in the patient journey.

What Happens When the Government Enters the Pharma Customer Journey?

August 21, 2026

Patient using an accessible pharmaceutical website with features for readable text, keyboard navigation, captions, and screen readers.

Can Every Patient Actually Use Your Pharma Website?

August 21, 2026

FDA Complete Response Letter on a pharmaceutical regulatory desk with clinical data and drug application documents

Your Drug Didn’t Get Approved. Now the FDA Can Tell Everyone...

August 20, 2026